R27 Solution/ Drops
NDC Package 63479-1827-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

R27 (adenosine triphosphate, arsenic trioxide, arabica coffee bean, lycopodium clavatum spore, pulsatilla vulgaris whole, datura stramonium, bilberry) solution/ dropses is for temporary relief of minor:red eyes*dry eyes*swollen eyes*eye pains*burning eyes*cloudiness of eyes**Claims based on traditional homeopathic practice, not accepted medical evidence. This formulation utilizes a solution/ drops delivery system. Marketed by Apex Energetics Inc., this product is identified by NDC 63479-1827.

Identification & Billing

NDC Package Code
63479-1827-1
Package Description
30 mL in 1 BOTTLE, GLASS
Product Code
63479-1827
11-Digit Billing Format
63479182701

Clinical Specifications

Proprietary Name
R27 Eye
Non-Proprietary Name
Adenosine Triphosphate, Arsenic Trioxide, Arabica Coffee Bean, Lycopodium Clavatum Spore, Pulsatilla Vulgaris Whole, Datura Stramonium, Bilberry
Substance Name
Adenosine Triphosphate; Arabica Coffee Bean; Arsenic Trioxide; Bilberry; Datura Stramonium; Lycopodium Clavatum Spore; Pulsatilla Vulgaris
Dosage Form
Solution/ Drops - A solution which is usually administered in a drop-wise fashion.
Administration Route
Sublingual - Administration beneath the tongue.
Active Ingredient(s)
Pharmacologic Class
Usage Information
For temporary relief of minor:red eyes*dry eyes*swollen eyes*eye pains*burning eyes*cloudiness of eyes**Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Regulatory & Marketing

Labeler Name
Apex Energetics Inc.
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
05-15-1998
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 63479-1827-1 identifies a specific commercial package of 30 ml in 1 bottle, glass of R27 Eye, a human over the counter drug labeled by Apex Energetics Inc.. This solution/ drops is formulated for sublingual use and contains adenosine triphosphate; arabica coffee bean; arsenic trioxide; bilberry; datura stramonium; lycopodium clavatum spore; pulsatilla vulgaris as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Apex Energetics Inc. on May 15, 1998. The current certification is valid through December 31, 2026.

How is this Apex Energetics Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 63479182701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
63479-1827-1
11-Digit CMS (5-4-2)
63479-1827-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.